Second- and third-generation drugs for immuno-oncology treatment—The more the better?

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Second- and third-generation drugs for immuno-oncology treatment—The more the better?
Authors
Keywords
Immuno-oncology, Novel antibodies, Molecular biology, Clinical development
Journal
EUROPEAN JOURNAL OF CANCER
Volume 74, Issue -, Pages 55-72
Publisher
Elsevier BV
Online
2017-02-10
DOI
10.1016/j.ejca.2017.01.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.